Sustained Cognitive Decline in HIV Infection: Relationship to CD4+ Cell Count, Plasma Viremia and p24 Antigenemia

References

• Buffet R, Agut H, Chieze F, et al. Virological markers in the cerebrospinal fluid from HIV-1 infected individuals. AIDS 1991; 5: 1419–1424
   Google Scholar
• Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWE 1987; 36(suppl 1S)3S–15S
   Google Scholar
• Conrad A J, Schmid P, Syndulko K, et al. Quantifying HIV-1 RNA using the polymerase chain reaction on cerebrospinal fluid and serum of seropositive individuals with and without neurologic abnormalities. Journal of the Acquired Immunodeficiency Syndrome and Human Retrovirology 1995; 10: 425–435
   Google Scholar
• Coombs R W, Collier A C, Allain J P, et al. Plasma viremia in human immunodeficiency virus infection. N Engl J Med 1989; 321: 1626–1631
   PubMed Web of Science ®Google Scholar
• Cornblath D R, McArthur J C. Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex. Neurology 1988; 38: 794–796
   PubMed Web of Science ®Google Scholar
• Dal Pan G J, Glass J D, McArthur J C. Clinicopathologic correlations of HIV-associated vacuolar myelopathy: An autopsy-based case-control study. Neurology 1994; 44: 2159–2164
   Google Scholar
• Farzadegan H, Chmiel J S, Odaka N, et al. Association of antibody to human immunodeficiency virus type 1 core protein (p24), CD4+ lymphocyte number, and AIDS-free time. J Infect Dis 1992; 166: 1217–1222
   Google Scholar
• Hinkin C H, VanGorp W G, Satz P, Weisman J D, Thommes J, Buckingham S. Depressed mood and its relationship to neuropsychological test performance in HIV-1 serapositive individuals. J Clin Exp Neuropsychol 1992; 14: 289–297
   PubMed Web of Science ®Google Scholar
• Janssen R S, Cornblath D R, Epstein L G, et al. Nomenclature and research case definitions for neurological manifestations of human immunodeficiency virus type-1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology 1991; 41: 778–785
   PubMedGoogle Scholar
• Kaslow R A, Ostrow D G, Detels R, Phair J P, Polk B F, Rinaldo C R. The Multicenter AIDS Cohort Study (MACS): Rationale, organization, and selected characteristics of the participants. Am J Epidemiol 1987; 126: 310–318
   PubMed Web of Science ®Google Scholar
• Kelen G D, Chanmugan A, Meyer W A, Farzedegan H, Stone D, Quinn T C. Detection of HIV-1 polymerase chain reaction and culture in seronegative intravenous drug users in an inner-city emergency department. Ann Emerg Med 1993; 22: 769–775
   Google Scholar
• Kewman D G, Vaishampayan N, Zald D, Han B. Cognitive Impairment in musculoskeletal pain patients. Int J Psychiatry Med 1991; 21: 253–262
   PubMed Web of Science ®Google Scholar
• Margolick J B, Farzadegan H, Hoover D R, Saah A J. Relationship between infectious cell-associated human immunodeficiency virus type 1 load, T lymphocyte subsets, and stage of infection in homosexual men. J Infect Dis 1996; 173: 468–471
   PubMedGoogle Scholar
• Mayeux R, Stern Y, Tang M X, et al. Mortality risks in gay men with human immunodeficiency virus infection and cognitive impairment. Neurology 1993; 43: 176–182
   PubMed Web of Science ®Google Scholar
• McArthur J C. Neurologic manifestations of ADDS. Medicine (Baltimore) 1987; 66: 407–437
   PubMed Web of Science ®Google Scholar
• McArthur J C, Hoover D R, Bacellar H, et al. Dementia in AIDS patients: incidence and risk factors. Neurology 1993; 43: 2245–2253
   PubMed Web of Science ®Google Scholar
• Mellors J W, Kingsley L A, Rinaldo C R, et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995; 122: 573–579
   PubMed Web of Science ®Google Scholar
• Miller R G, Carson P J, Moussavi R S, Green A T, Baker A J, Weiner M W. Fatigue and myalgia in AIDS patients. Neurology 1991; 41: 1603–1607
   PubMed Web of Science ®Google Scholar
• Pantaleo G, Graziosi C, Butini L, et al. Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proc Natl Acad Sci USA 1991; 88: 9838–9842
   PubMed Web of Science ®Google Scholar
• Royal W, Seines O A, Concha M, Nance-Sproson T E, McArthur J C. Cerebrospinal fluid HIV-1 p24 antigen levels in HIV-1-related dementia. Ann Neurol 1994; 36: 32–39
   Google Scholar
• Sacktor N C, Bacellar H, Hoover D R, et al. Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death. J Neurovirol 1996; 2: 404–410
   PubMed Web of Science ®Google Scholar
• Schmid P, Conrad A J, Syndulko K, et al. Quantifying HIV-1 proviral DNA using the polymerase chain reaction on cerebrospinal fluid and blood of seropositive individuals with and without neurologic abnormalities. J Acquir Immune Defic Syndr 1994; 7: 777–788
   Google Scholar
• Schooley R T. Correlation between viral load measurements and outcome in clinical trials of antiviral drugs. AIDS 1995; 9(Suppl)S15–S19
   Google Scholar
• Seines O A, Miller E, McArthur J C, et al. HIV-1 infection: No evidence of cognitive decline during the asymptomatic stages. Neurology 1990; 40: 204–208
   PubMed Web of Science ®Google Scholar
• Seines O A, Miller E N. Development of a screening battery for HIV-related cognitive impairment: the MACS experience. Neuropsychology of HIV Infection: Current Research and New Directions, I Grant, A Martin. Oxford University Press, New York 1994; 176–187
   Google Scholar
• Sidtis J J, Gatsonis C, Price R W, et al. Zidovudine Treatment of the AIDS Dementia Complex: Results of a Placebo-Controlled Trial. Am Neurol 1993; 33: 343–349
   PubMed Web of Science ®Google Scholar
• Singer E J, Syndulko K, Fahy-Chandon B N, et al. Cerebrospinal fluid p24 antigen levels and intrathecal immunoglobulin G synthesis are associated with cognitive disease severity in HIV-1. AIDS 1994; 8: 197–204
   Google Scholar